LifeTech Scientific Corporation (HK:1302) has released an update.
LifeTech Scientific Corporation reported a slight revenue growth of 2.1% in their interim results for the first half of 2024, with turnover reaching approximately RMB652.8 million. Despite this, the company experienced a 6.6% drop in net profit, attributed mainly to increased staff costs and a decrease in foreign exchange gains. The Board has decided not to issue any interim dividends for this period.
For further insights into HK:1302 stock, check out TipRanks’ Stock Analysis page.
